A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer

Metastatic castration-resistant prostate cancer (mCRPC) is an immunologically cold disease with dismal outcomes. Cryoablation destroys cancer tissue, releases tumor-associated antigens and creates a pro-inflammatory microenvironment, while dendritic cells (DCs) activate immune responses through proc...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomsen, Liv Cecilie Vestrheim, Honoré, Alfred, Reisæter, Lars Anders Rokne, Almås, Bjarte, Børretzen, Astrid, Helle, Svein Inge, Førde, Kristina, Kristoffersen, Einar Klæboe, Kaada, Silje Helland, Melve, Guro Kristin, Haslerud, Torjan Magne, Biermann, Martin, Bigalke, Iris, Kvalheim, Gunnar, Azeem, Waqas, Olsen, Jan Roger, Gabriel, Benjamin, Knappskog, Stian, Halvorsen, Ole Johan, Akslen, Lars Andreas, Bahn, Duke, Pantel, Klaus, Riethdorf, Sabine, Ragde, Haakon, Gjertsen, Bjørn Tore, Øyan, Anne Margrete, Kalland, Karl-Henning, Beisland, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264291/
https://www.ncbi.nlm.nih.gov/pubmed/36939854
http://dx.doi.org/10.1007/s00262-023-03421-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264291/
https://www.ncbi.nlm.nih.gov/pubmed/36939854
http://dx.doi.org/10.1007/s00262-023-03421-7

Ejemplares similares